City
Epaper

COVID-19: Covaxin for children above 2 yrs to be available by September

By Lokmat English Desk | Published: June 23, 2021 5:58 PM

The second wave of corona in the country seems to be waning. However, the third wave of corona has ...

Open in App

The second wave of corona in the country seems to be waning. However, the third wave of corona has been repeatedly warned by experts. The government has already started preparations in this regard. More and more emphasis is being placed on vaccination for corona control. The third wave of corona could have a greater impact on young children, experts say. In that context, Dr. Randeep Guleria, Director, Delhi AIIMS Hospital, has given important information about vaccination for children.

Considering the threat of corona, trials of vaccine on young children have been started in some parts of the country. The central government is working to protect children from the third wave of corona. AIIMS Patna and Delhi are testing Covaxin vaccine on children between the ages of 2 and 12. DCGI had approved Bharat Biotech for Phase II and III tests on children.

Speaking about this, Dr. Randeep Guleria said the data would be available by September after testing of phases II and III of the Covaxin. Also, if Pfizer-Biotech is approved in India, it could be an alternative to the children's vaccine. Dr Guleria also said that there was no data available in India or internationally that children would be infected in the next wave of corona.

Tags: CovaxinCoronavirus VaccineCoronavirusCovid-19Randeep Guleria
Open in App

Related Stories

NationalSingapore’s New COVID Wave Milder: No Need for Panic, Assures Tamil Nadu Government

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

HealthGood News! Scientists Develop All-in-One Vaccine Effective Against Current and Future Coronavirus Variants

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

National Realted Stories

NationalKerala Assembly session likely from June 10

NationalSaran violence may polarise voters in remaining 16 Lok Sabha seats in Bihar

NationalPrajwal Revanna Sex Scandal: SIT Helpline Gets Calls From 30 Victims

NationalDelhi Fire: Massive Blaze Erupts in Carnival Resort in Alipur (Watch Video)

NationalStudent’s death sparks protest in Telangana paramedical college